SIRT1 alleviates DCM by inhibiting transcription factors that impair cardiac function, such as NF-κB and FOXO3, and increasing the expression of some factors that protect cardiac function, such as eNOS, PGC-1α, and ERK1/2 [148,149]. The gene discussed is PPARGC1A; the disease is familial dilated cardiomyopathy.